Transcriptional control of embryonic and induced pluripotent stem cells

Epigenomics

Volumn 3, Issue 3, 2011, Pages 323-343

  Guenther, Matthew G ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

chromatin; embryonic stem cells; epigenetic; ESC; histone modification; induced pluripotent stem cell; iPSC; Oct4; pluripotency; reprogramming; Sox2; transcription

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; MESSENGER RNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RNA POLYMERASE II; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; UNTRANSLATED RNA; WNT PROTEIN;

BLASTOCYST; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENOME ANALYSIS; HISTONE MODIFICATION; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

CHROMATIN; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 79959954116     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.11.15     Document Type: Review

References (269)

1. Jaenisch R, Young R: Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132(4), 567-582 (2008). (Pubitemid 351253686)
2. Orkin SH, Wang J, Kim J, et al.: The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb. Symp. Quant. Biol. 73, 95-202 (2008).
3. Hochedlinger K, Plath K: Epigenetic reprogramming and induced pluripotency. Development 136(4), 509-523 (2009).
4. Chen X, Vega VB, Ng HH: Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb. Symp. Quant. Biol. 73, 203-209 (2008).
5. Tapscott SJ: The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132(12), 2685-2695 (2005). (Pubitemid 40932860)
6. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM: A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 10(4), 252-263 (2009).
7. Mallo M, Welik, DM, Deschamps J: Hox genes and regional patterning of the vertebrate body plan. Dev. Biol. 344(1), 7-15 (2010).
8. Fuda NJ, Ardehali MB, Lis JT: Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461(7261), 186-192 (2009).
9. Li B, Carey M, Workman JL: The role of chromatin during transcription. Cell 128(4), 707-719 (2007). (Pubitemid 46273570)
10. Rosenfeld MG, Lunyak VV, Glass CK: Sensors and signals: a coactivator/corepressor/ epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20(11), 1405-1428 (2006). (Pubitemid 43830648)
11. Silva J, Smith A: Capturing pluripotency. Cell 132(4), 532-536 (2008). (Pubitemid 351253697)
12. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24(4), 372-376 (2000). (Pubitemid 30187435)
13. Nichols J, Zevnik B, Anastassiadis K, et al.: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3), 379-391 (1998). (Pubitemid 28507326)
14. Rosner MH, Vigano MA, Ozato K, et al.: A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345(6277), 686-692 (1990).
15. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P: New type of POU domain in germ line-specific protein Oct-4. Nature 344(6265), 435-439 (1990).
16. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60(3), 461-472 (1990).
17. Palmieri SL, Peter W, Hess H, Scholer HR: Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 166(1), 259-267 (1994). (Pubitemid 24374763)
18. Chambers I, Smith A: Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23(43), 7150-7160 (2004). (Pubitemid 39382149)
19. Mitsui K, Tokuzawa Y, Itoh H, et al.: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5), 631-642 (2003). (Pubitemid 36694188)
20. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R: Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17(1), 126-140 (2003). (Pubitemid 36062514)
21. Ambrosetti DC, Scholer HR, Dailey L, Basilico C: Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 275(30), 23387-23397 (2000). (Pubitemid 30646242)
22. Masui S, Nakatake Y, Toyooka Y, et al.: Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9(6), 625-635 (2007). (Pubitemid 47214724)
23. Chambers I, Silva J, Colby D, et al.: Nanog safeguards pluripotency and mediates germline development. Nature 450(7173), 1230-1234 (2007).
24. Silva J, Nichols J, Theunissen TW, et al.: Nanog is the gateway to the pluripotent ground state. Cell 138(4), 722-737 (2009).
25. Boyer LA, Lee TI, Cole MF, et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6), 947-956 (2005). (Pubitemid 41345211)
26. Loh YH, Wu Q, Chew JL, et al.: The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38(4), 431-440 (2006).
27. Smith SB, Watada H, Scheel DW, Mrejen C, German MS: Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter. J. Biol. Chem. 275(47), 36910-36919 (2000). (Pubitemid 32002104)
28. Laffitte BA, Joseph SB, Walczak R, et al.: Autoregulation of the human liver X receptor a promoter. Mol. Cell Biol. 21(22), 7558-7568 (2001). (Pubitemid 32988767)
29. Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H: Positive autoregulation of the myogenic determination gene MyoD1. Cell 58(2), 241-248 (1989). (Pubitemid 19191406)
30. Kielbasa SM, Vingron M: Transcriptional autoregulatory loops are highly conserved in vertebrate evolution. PLoS ONE 3(9), e3210 (2008).
31. Odom DT, Dowell RD, Jacobsen ES, et al.: Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol. 2, 2006.0017 (2006).
32. Marson A, Levine SS, Cole MF, et al.: Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134(3), 521-533 (2008).
33. Chen X, Xu H, Yuan P, et al.: Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6), 1106-1117 (2008). (Pubitemid 351787745)
34. Chew JL, Loh YH, Zhang W, et al.: Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell Biol. 25(14), 6031-6046 (2005). (Pubitemid 40946556)
35. Matoba R, Niwa H, Masui S, et al.: Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 1, e26 (2006).
36. Sharov AA, Masui S, Sharova LV, et al.: Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genomics 9, 269 (2008).
37. Zhang J, Tam WL, Tong GQ, et al.: Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 8(10), 1114-1123 (2006). (Pubitemid 44473607)
38. Wu Q, Chen X, Zhang J, et al.: Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J. Biol. Chem. 281(34), 24090-24094 (2006). (Pubitemid 44274183)
39. Lim CY, Tam WL, Zhang J, et al.: Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 3(5), 543-554 (2008).
40. Yang J, Chai L, Fowles TC, et al.: Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc. Natl Acad. Sci. USA 105(50), 19756-19761 (2008).
41. Kim J, Chu J, Shen X, Wang J, Orkin SH: An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132(6), 1049-1061 (2008). (Pubitemid 351381745)
42. Ivanova N, Dobrin R, Lu R, et al.: Dissecting self-renewal in stem cells with RNA interference. Nature 442(7102), 533-538 (2006). (Pubitemid 44167907)
43. Zhang X, Zhang J, Wang T, Esteban MA, Pei D: Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 283(51), 35825-35833 (2008).
44. Jiang J, Chan YS, Loh YH, et al.: A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10(3), 353-360 (2008). (Pubitemid 351331023)
45. Tam WL, Lim CY, Han J, et al.: T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells 26(8), 2019-2031 (2008).
46. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA: Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 22(6), 746-755 (2008). (Pubitemid 351439106)
47. Smith AG: Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 17, 435-462 (2001). (Pubitemid 33096183)
48. Okita K, Yamanaka S: Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr. Stem Cell Res. Ther. 1(1), 103-111 (2006).
49. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH: Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10(1), 55-63 (2004). (Pubitemid 38524699)
50. Smith SK, Charnock-Jones DS, Sharkey AM: The role of leukemia inhibitory factor and interleukin-6 in human reproduction. Hum. Reprod. 13(Suppl. 3), 237-243; discussion 244-236 (1998).
51. Williams RL, Hilton DJ, Pease S, et al.: Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336(6200), 684-687 (1988). (Pubitemid 19007951)
52. Ying QL, Nichols J, Chambers I, Smith A: BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115(3), 281-292 (2003). (Pubitemid 37487702)
53. Lluis F, Pedone E, Pepe S, Cosma MP: Periodic activation of Wnt/b-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell 3(5), 493-507 (2008).
54. Maherali N, Hochedlinger K: TGFb signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 19(20), 1718-1723 (2009).
55. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A: Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6(10), e253 (2008).
56. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130(1), 77-88 (2007). (Pubitemid 47031323)
57. Zeitlinger J, Stark A, Kellis M, et al.: RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 39(12), 1512-1516 (2007). (Pubitemid 350191345)
58. Rahl PB, Lin CY, Seila AC, et al.: c-Myc regulates transcriptional pause release. Cell 141(3), 432-445 (2010).
59. Muse GW, Gilchrist DA, Nechaev S, et al.: RNA polymerase is poised for activation across the genome. Nat. Genet. 39(12), 1507-1511 (2007). (Pubitemid 350191341)
60. Berger SL: The complex language of chromatin regulation during transcription. Nature 447(7143), 407-412 (2007). (Pubitemid 46816746)
61. Kouzarides T: Chromatin modifications and their function. Cell 128(4), 693-705 (2007). (Pubitemid 46273577)
62. Lee TI, Jenner RG, Boyer LA, et al.: Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125(2), 301-313 (2006). (Pubitemid 44313811)
63. Barski A, Cuddapah S, Cui K, et al.: High-resolution profiling of histone methylations in the human genome. Cell 129(4), 823-837 (2007). (Pubitemid 46802390)
64. Pan G, Tian S, Nie J, et al.: Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1(3), 299-312 (2007). (Pubitemid 47355329)
65. Bernstein BE, Mikkelsen TS, Xie X, et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
66. Zhao XD, Han X, Chew JL, et al.: Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1(3), 286-298 (2007). (Pubitemid 47370914)
67. Mikkelsen TS, Ku M, Jaffe DB, et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007). (Pubitemid 47206934)
68. Meissner A, Mikkelsen TS, Gu H, et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008).
69. Mikkelsen TS, Hanna J, Zhang X, et al.: Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200), 49-55 (2008). (Pubitemid 351931978)
70. Smith E, Shilatifard A: The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol. Cell. 40(5), 689-701 (2010).
71. Gardner KE, Allis CD, Strahl BD: Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409(1), 36-46 (2011).
72. Pardo M, Lang B, Yu L, et al.: An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6(4), 382-395 (2010).
73. Van Den Berg DL, Snoek T, Mullin NP, et al.: An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6(4), 369-381 (2010).
74. Hemberger M, Dean W, Reik W: Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddingtons canal. Nat. Rev. Mol. Cell Biol. 10(8), 526-537 (2009).
75. Yang XJ, Seto E: The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9(3), 206-218 (2008). (Pubitemid 351301825)
76. Cunliffe VT: Eloquent silence: developmental functions of class I histone deacetylases. Curr. Opin. Genet. Dev. 18(5), 404-410 (2008). (Pubitemid 50308559)
77. Fazzio TG, Huff JT, Panning B: An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134(1), 162-174 (2008). (Pubitemid 351905738)
78. Zhong X, Jin Y: Critical roles of coactivator p300 in mouse embryonic stem cell differentiation and Nanog expression. J. Biol. Chem. 284(14), 9168-9175 (2009).
79. Chia NY, Chan YS, Feng B, et al.: A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468(7321), 316-320 (2010)
80. Visel A, Blow MJ, Li Z, et al.: ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457(7231), 854-858 (2009).
81. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J: A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470(7333), 279-283 (2010).
82. Creyghton MP, Cheng AW, Welstead GG, et al.: Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107(50), 21931-21936 (2010).
83. Heintzman ND, Hon GC, Hawkins RD, et al.: Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459(7243), 108-112 (2009).
84. Liang J, Wan M, Zhang Y, et al.: Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10(6), 731-739 (2008). (Pubitemid 351772939)
85. Yuri S, Fujimura S, Nimura K, et al.: Sall4 is essential for stabilization, but not for pluripotency, of embryonic stem cells by repressing aberrant trophectoderm gene expression. Stem Cells 27(4), 796-805 (2009).
86. Lu J, Jeong HW, Kong N, et al.: Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS ONE 4(5), e5577 (2009).
87. Lauberth SM, Rauchman M: A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex. J. Biol. Chem. 281(33), 23922-23931 (2006). (Pubitemid 44274167)
88. Kaji K, Caballero IM, Macleod R, Nichols J, Wilson VA, Hendrich B: The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 8(3), 285-292 (2006). (Pubitemid 43336071)
89. Kaji K, Nichols J, Hendrich B: Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development 134(6), 1123-1132 (2007). (Pubitemid 46630080)
90. Lagger S, Meunier D, Mikula M, et al.: Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. EMBO J. 29(23), 3992-4007 (2010).
91. Dovey OM, Foster CT, Cowley SM: Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 107(18), 8242-8247 (2010).
92. Pietersen AM, Van Lohuizen M: Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20(2), 201-207 (2008).
93. Schuettengruber B, Cavalli G: Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development 136(21), 3531-3542 (2009).
94. Lewis EB: A gene complex controlling segmentation in Drosophila. Nature 276(5688), 565-570 (1978).
95. Schuettengruber B, Ganapathi M, Leblanc B, et al.: Functional anatomy of polycomb and trithorax chromatin landscapes in Drosophila embryos. PLoS Biol. 7(1), e13 (2009).
96. Schwartz YB, Pirrotta V: Polycomb complexes and epigenetic states. Curr. Opin. Cell Biol. 20(3), 266-273 (2008).
97. Kerppola TK: Polycomb group complexes - many combinations, many functions. Trends Cell Biol. 19(12), 692-704 (2009).
98. Leeb M, Pasini D, Novatchkova M, Jaritz M, Helin K, Wutz A: Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev. 24(3), 265-276 (2010).
99. OCarroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T: The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell Biol. 21(13), 4330-4336 (2001). (Pubitemid 32565314)
100. Wang J, Mager J, Schnedier E, Magnuson T: The mouse PcG gene Eed is required for Hox gene repression and extraembryonic development. Mamm. Genome 13(9), 493-503 (2002). (Pubitemid 34913601)
101. Voncken JW, Roelen BA, Roefs M, et al.: Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc. Natl Acad. Sci. USA 100(5), 2468-2473 (2003). (Pubitemid 36297522)
102. Cao R, Wang L, Wang H, et al.: Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298(5595), 1039-1043 (2002). (Pubitemid 35247314)
103. Cao R, Zhang Y: SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell. 15(1), 57-67 (2004). (Pubitemid 38850219)
104. Czermin B, Melfi R, Mccabe D, Seitz V, Imhof A, Pirrotta V: Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111(2), 185-196 (2002). (Pubitemid 35292439)
105. Kirmizis A, Bartley SM, Kuzmichev A, et al.: Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18(13), 1592-1605 (2004). (Pubitemid 38868910)
106. Kuzmichev A, Nishioka K, Erdjument- Bromage H, Tempst P, Reinberg D: Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16(22), 2893-2905 (2002). (Pubitemid 35334738)
107. Muller J, Hart CM, Francis NJ, et al.: Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111(2), 197-208 (2002). (Pubitemid 35292440)
108. De Napoles M, Mermoud JE, Wakao R, et al.: Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev. Cell 7(5), 663-676 (2004). (Pubitemid 39462687)
109. Simon JA, Kingston RE: Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10(10), 697-708 (2009).
110. Wang H, Wang L, Erdjument-Bromage H, et al.: Role of histone H2A ubiquitination in Polycomb silencing. Nature 431(7010), 873-878 (2004). (Pubitemid 39434086)
111. Surface LE, Thornton SR, Boyer LA: Polycomb group proteins set the stage for early lineage commitment. Cell Stem Cell 7(3), 288-298 (2010).
112. Shen X, Kim W, Fujiwara Y, et al.: Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139(7), 1303-1314 (2009).
113. Pasini D, Cloos PA, Walfridsson J, et al.: JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464(7286), 306-310 (2010).
114. Peng JC, Valouev A, Swigut T, et al.: Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139(7), 1290-1302 (2009).
115. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D: Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 24(4), 368-380 (2010).
116. Landeira D, Sauer S, Poot R, et al.: Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat. Cell Biol. 12(6), 618-624 (2010).
117. Kanhere A, Viiri K, Araujo C, et al.: Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell. 38(5), 675-688 (2010).
118. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT: Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322(5902), 750-756 (2008).
119. Stock JK, Giadrossi S, Casanova M, et al.: Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol. 9(12), 1428-1435 (2007). (Pubitemid 350201756)
120. Zhou W, Zhu P, Wang J, et al.: Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol. Cell. 29(1), 69-80 (2008).
121. Breiling A, Turner BM, Bianchi ME, Orlando V: General transcription factors bind promoters repressed by Polycomb group proteins. Nature 412(6847), 651-655 (2001).
122. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T: Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6(1), 73-77 (2004). (Pubitemid 38425733)
123. Bernstein BE, Humphrey EL, Erlich RL, et al.: Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl Acad. Sci. USA 99(13), 8695-8700 (2002). (Pubitemid 34693622)
124. Santos-Rosa H, Schneider R, Bannister AJ, et al.: Active genes are tri-methylated at K4 of histone H3. Nature 419(6905), 407-411 (2002).
125. Ng HH, Robert F, Young RA, Struhl K: Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell 11(3), 709-719 (2003). (Pubitemid 36385124)
126. Guenther MG, Jenner RG, Chevalier B, et al.: Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl Acad. Sci. USA 102(24), 8603-8608 (2005). (Pubitemid 40862782)
127. Breen TR, Harte PJ: Molecular characterization of the trithorax gene, a positive regulator of homeotic gene expression in Drosophila. Mech. Dev. 35(2), 113-127 (1991).
128. Sedkov Y, Tillib S, Mizrokhi L, Mazo A: The bithorax complex is regulated by trithorax earlier during Drosophila embryogenesis than is the Antennapedia complex, correlating with a bithorax-like expression pattern of distinct early trithorax transcripts. Development 120(7), 1907-1917 (1994).
129. Ingham PW: trithorax and the regulation of homeotic gene expression in Drosophila: a historical perspective. Int. J. Dev. Biol. 42(3), 423-429 (1998). (Pubitemid 28264376)
130. Eissenberg JC, Shilatifard A: Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev. Biol. 339(2), 240-249 (2009).
131. Hughes CM, Rozenblatt-Rosen O, Milne TA, et al.: Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell. 13(4), 587-597 (2004). (Pubitemid 38299385)
132. Krogan NJ, Dover J, Wood A, et al.: The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol. Cell. 11(3), 721-729 (2003). (Pubitemid 36385125)
133. Miller T, Krogan NJ, Dover J, et al.: COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl Acad. Sci. USA 98(23), 12902-12907 (2001). (Pubitemid 33051292)
134. Shilatifard A: Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 20(3), 341-348 (2008).
135. Ding L, Paszkowski-Rogacz M, Nitzsche A, et al.: A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4(5), 403-415 (2009).
136. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA: SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 23(21), 2484-2489 (2009).
137. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 23(7), 837-848 (2009).
138. Kagey MH, Newman JJ, Bilodeau S, et al.: Mediator and cohesin connect gene expression and chromatin architecture. Nature 467(7314), 430-435 (2010).
139. Nasmyth K, Haering CH: Cohesin: its roles and mechanisms. Annu. Rev. Genet. 43, 525-558 (2009).
140. Wood AJ, Severson AF, Meyer BJ: Condensin and cohesin complexity: the expanding repertoire of functions. Nat. Rev. Genet. 11(6), 391-404 (2010).
141. Liu J, Krantz ID: Cornelia de Lange syndrome, cohesin, and beyond. Clin. Genet. 76(4), 303-314 (2009).
142. Malik S, Roeder RG: The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet. 11(11), 761-772 (2010).
143. Ho L, Crabtree GR: Chromatin remodelling during development. Nature 463(7280), 474-484 (2010).
144. Clapier CR, Cairns BR: The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78, 273-304 (2009).
145. Gaspar-Maia A, Alajem A, Polesso F, et al.: Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 460(7257), 863-868 (2009).
146. Bultman SJ, Gebuhr TC, Pan H, Svoboda P, Schultz RM, Magnuson T: Maternal BRG1 regulates zygotic genome activation in the mouse. Genes Dev. 20(13), 1744-1754 (2006). (Pubitemid 43992883)
147. Gao X, Tate P, Hu P, Tjian R, Skarnes WC, Wang Z: ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc. Natl Acad. Sci. USA 105(18), 6656-6661 (2008). (Pubitemid 351754562)
148. Guidi CJ, Sands AT, Zambrowicz BP, et al.: Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol. Cell Biol. 21(10), 3598-3603 (2001). (Pubitemid 32381795)
149. Kim JK, Huh SO, Choi H, et al.: Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol. Cell Biol. 21(22), 7787-7795 (2001). (Pubitemid 32988787)
150. Lickert H, Takeuchi JK, Von Both I, et al.: Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432(7013), 107-112 (2004). (Pubitemid 39490836)
151. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M: The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1(6), 500-506 (2000).
152. Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR: An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc. Natl Acad. Sci. USA 106(13), 5187-5191 (2009).
153. Lessard JA, Crabtree GR: Chromatin regulatory mechanisms in pluripotency. Annu. Rev. Cell Dev. Biol. 26, 503-532 (2010).
154. Singhal N, Graumann J, Wu G, et al.: Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141(6), 943-955 (2010).
155. Bernstein BE, Kamal M, Lindblad-Toh K, et al.: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2), 169-181 (2005). (Pubitemid 40174761)
156. Boyer LA, Plath K, Zeitlinger J, et al.: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 349-353 (2006). (Pubitemid 44050199)
157. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K: Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20(9), 1123-1136 (2006).
158. Bernstein BE, Meissner A, Lander ES: The mammalian epigenome. Cell 128(4), 669-681 (2007). (Pubitemid 46273573)
159. Guenther MG, Lawton LN, Rozovskaia T, et al.: Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 22(24), 3403-3408 (2008).
160. Schwartz S, Meshorer E, Ast G: Chromatin organization marks exon-intron structure. Nat. Struct. Mol. Biol. 16(9), 990-995 (2009).
161. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J: Differential chromatin marking of introns and expressed exons by H3K36me3. Nat. Genet. 41(3), 376-381 (2009).
162. Andersson R, Enroth S, Rada-Iglesias A, Wadelius C, Komorowski J: Nucleosomes are well positioned in exons and carry characteristic histone modifications. Genome Res. 19(10), 1732-1741 (2009).
163. Tilgner H, Nikolaou C, Althammer S, et al.: Nucleosome positioning as a determinant of exon recognition. Nat. Struct. Mol. Biol. 16(9), 996-1001 (2009).
164. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T: Regulation of alternative splicing by histone modifications. Science 327(5968), 996-1000 (2010).
165. Guttman M, Amit I, Garber M, et al.: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458(7235), 223-227 (2009).
166. Azuara V, Perry P, Sauer S, et al.: Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8(5), 532-538 (2006).
167. Grewal SI, Jia S: Heterochromatin revisited. Nat. Rev. Genet. 8(1), 35-46 (2007). (Pubitemid 46006048)
168. Yeap LS, Hayashi K, Surani MA: ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin 2(1), 12 (2009).
169. Yuan P, Han J, Guo G, et al.: Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 23(21), 2507-2520 (2009).
170. Rowe HM, Jakobsson J, Mesnard D, et al.: KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463(7278), 237-240 (2010).
171. Matsui T, Leung D, Miyashita H, et al.: Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464(7290), 927-931 (2010).
172. Tachibana M, Sugimoto K, Nozaki M, et al.: G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16(14), 1779-1791 (2002). (Pubitemid 34803894)
173. Lehnertz B, Ueda Y, Derijck AA, et al.: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13(14), 1192-1200 (2003). (Pubitemid 36872941)
174. Alder O, Lavial F, Helness A, et al.: Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment. Development 137(15), 2483-2492 (2010).
175. Maniatis T, Falvo JV, Kim TH, et al.: Structure and function of the interferon-b enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620 (1998).
176. Levine M, Tjian R: Transcription regulation and animal diversity. Nature 424(6945), 147-151 (2003). (Pubitemid 36858677)
177. Bulger M, Groudine M: Functional and mechanistic diversity of distal transcription enhancers. Cell 144(3), 327-339 (2011).
178. Kafri T, Ariel M, Brandeis M, et al.: Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev. 6(5), 705-714 (1992).
179. Monk M, Boubelik M, Lehnert S: Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99(3), 371-382 (1987). (Pubitemid 17048855)
180. Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31(2), 89-97 (2006). (Pubitemid 43221841)
181. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999). (Pubitemid 29519904)
182. Illingworth RS, Bird AP: CpG islands - a rough guide. FEBS Lett. 583(11), 1713-1720 (2009).
183. Ooi SK, Qiu C, Bernstein E, et al.: DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448(7154), 714-717 (2007). (Pubitemid 47236857)
184. Thomson JSP, Selfridge J, Clouaire T, et al.: CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464, 1082-1086 (2010).
185. Lister R, Pelizzola M, Dowen RH, et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
186. Fouse SD, Shen Y, Pellegrini M, et al.: Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2(2), 160-169 (2008). (Pubitemid 351168712)
187. Farthing CR, Ficz G, Ng RK, et al.: Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet. 4(6), e1000116 (2008).
188. Illingworth R, Kerr A, Desousa D, et al.: A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 6(1), e22 (2008).
189. Mohn F, Weber M, Rebhan M, et al.: Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell. 30(6), 755-766 (2008).
190. Wilusz JE, Sunwoo H, Spector DL: Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23(13), 1494-1504 (2009).
191. Zaratiegui M, Irvine DV, Martienssen RA: Noncoding RNAs and gene silencing. Cell 128(4), 763-776 (2007). (Pubitemid 46273580)
192. Mercer TR, Dinger ME, Mattick JS: Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10(3), 155-159 (2009).
193. Pauli A, Rinn JL, Schier AF: Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 12(2), 136-149 (2011).
194. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233 (2009).
195. Kanellopoulou C, Muljo SA, Kung AL, et al.: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19(4), 489-501 (2005). (Pubitemid 40256280)
196. Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ: Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl Acad. Sci. USA 102(34), 12135-12140 (2005). (Pubitemid 41291141)
197. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R: DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39(3), 380-385 (2007). (Pubitemid 46328490)
198. Barroso-Deljesus A, Romero-Lopez C, Lucena-Aguilar G, et al.: Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol. Cell Biol. 28(21), 6609-6619 (2008).
199. Card DA, Hebbar PB, Li L, et al.: Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol. Cell Biol. 28(20), 6426-6438 (2008).
200. Sinkkonen L, Hugenschmidt T, Berninger P, et al.: MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15(3), 259-267 (2008). (Pubitemid 351654045)
201. Benetti R, Gonzalo S, Jaco I, et al.: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol. 15(3), 268-279 (2008). (Pubitemid 351654050)
202. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455(7216), 1124-1128 (2008).
203. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137(4), 647-658 (2009).
204. Rinn JL, Kertesz M, Wang JK, et al.: Functional demarcation of active and silent chromatin domains in human Hox loci by noncoding RNAs. Cell 129(7), 1311-1323 (2007). (Pubitemid 46962090)
205. Pandey RR, Mondal T, Mohammad F, et al.: Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell. 32(2), 232-246 (2008).
206. Yap KL, Li S, Munoz-Cabello AM, et al.: Molecular Interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38(5), 662-674 (2010).
207. Gupta RA, Shah N, Wang KC, et al.: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464(7291), 1071-1076 (2010).
208. Khalil AM, Guttman M, Huarte M, et al.: Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106(28), 11667-11672 (2009).
209. Tsai MC, Manor O, Wan Y, et al.: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329(5992), 689-693 (2010).
210. Core LJ, Waterfall JJ, Lis JT: Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322(5909), 1845-1848 (2008).
211. He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW: The antisense transcriptomes of human cells. Science 322(5909), 1855-1857 (2008).
212. Seila AC, Calabrese JM, Levine SS, et al.: Divergent transcription from active promoters. Science 322(5909), 1849-1851 (2008).
213. Guenther MG, Young RA: Repressive transcription. Science 329(5988), 150-151 (2010).
214. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
215. Yamanaka S, Blau HM: Nuclear reprogramming to a pluripotent state by three approaches. Nature 465(7299), 704-712 (2010).
216. Saha K, Jaenisch R: Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5(6), 584-595 (2009).
217. Kiskinis E, Eggan K: Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 120(1), 51-59 (2010).
218. Smith KP, Luong MX, Stein GS: Pluripotency: toward a gold standard for human ES and iPS cells. J. Cell Physiol. 220(1), 21-29 (2009).
219. Hanna JH, Saha K, Jaenisch R: Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143(4), 508-525 (2010).
220. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317 (2007). (Pubitemid 47080336)
221. Kang L, Wang J, Zhang Y, Kou Z, Gao S: iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5(2), 135-138 (2009).
222. Boland MJ, Hazen JL, Nazor KL, et al.: Adult mice generated from induced pluripotent stem cells. Nature 461(7260), 91-94 (2009).
223. Wernig M, Meissner A, Foreman R, et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007). (Pubitemid 47080337)
224. Zhao XY, Li W, Lv Z, et al.: iPS cells produce viable mice through tetraploid complementation. Nature 461(7260), 86-90 (2009).
225. Hu BY, Weick JP, Yu J, et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107(9), 4335-4340 (2010).
226. Feng Q, Lu SJ, Klimanskaya I, et al.: Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28(4), 704-712 (2010).
227. Nakagawa M, Koyanagi M, Tanabe K, et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1), 101-106 (2008).
228. Yu J, Vodyanik MA, Smuga-Otto K, et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
229. Wernig M, Meissner A, Cassady JP, Jaenisch R: c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2(1), 10-12 (2008).
230. Stadtfeld M, Hochedlinger K: Induced pluripotency: history, mechanisms, and applications. Genes Dev. 24(20), 2239-2263 (2010).
231. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S: Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3(5), 568-574 (2008).
232. Heng JC, Feng B, Han J, et al.: The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6(2), 167-174 (2010).
233. Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R: A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3(3), 346-353 (2008).
234. Wernig M, Lengner CJ, Hanna J, et al.: A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26(8), 916-924 (2008).
235. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K: A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3(3), 340-345 (2008).
236. Sridharan R, Tchieu J, Mason MJ, et al.: Role of the murine reprogramming factors in the induction of pluripotency. Cell 136(2), 364-377 (2009).
237. Huangfu D, Maehr R, Guo W, et al.: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26(7), 795-797 (2008). (Pubitemid 351961456)
238. Huangfu D, Osafune K, Maehr R, et al.: Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26(11), 1269-1275 (2008).
239. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S: A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2(6), 525-528 (2008). (Pubitemid 351729222)
240. Marson A, Foreman R, Chevalier B, et al.: Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3(2), 132-135 (2008).
241. Judson RL, Babiarz JE, Venere M, Blelloch R: Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27(5), 459-461 (2009).
242. Loewer S, Cabili MN, Guttman M, et al.: Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 42(12), 1113-1117 (2010).
243. Chin MH, Mason MJ, Xie W, et al.: Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1), 111-123 (2009).
244. Guenther MG, Frampton GM, Soldner F, et al.: Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2), 249-257 (2010).
245. Soldner F, Hockemeyer D, Beard C, et al.: Parkinsons disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5), 964-977 (2009).
246. Gidekel S, Bergman Y: A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277(37), 34521-34530 (2002).
247. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H: DNA methylation represses transcription in vivo. Nat. Genet. 22(2), 203-206 (1999).
248. Popp C, Dean W, Feng S, et al.: Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463(7284), 1101-1105 (2010).
249. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM: Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463(7284), 1042-1047 (2010).
250. Kim K, Doi A, Wen B, et al.: Epigenetic memory in induced pluripotent stem cells. Nature 467(7313), 285-290 (2010).
251. Doi A, Park IH, Wen B, et al.: Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41(12), 1350-1353 (2009).
252. Miura K, Okada Y, Aoi T, et al.: Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27(8), 743-745 (2009).
253. Lister R, Pelizzola M, Kida YS, et al.: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471(7336), 68-73 (2011).
254. Bock C, Kiskinis E, Verstappen G, et al.: Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3), 439-452 (2011).
255. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, Wu JC: MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. 18(5), 749-758 (2009).
256. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR: Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS ONE 4(9), e7076 (2009).
257. Chin MH, Pellegrini M, Plath K, Lowry WE: Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7(2), 263-269 (2010).
258. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC: Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE 5(2), e8975 (2010).
259. Newman AM, Cooper JB: Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7(2), 258-262 (2010).
260. Stadtfeld M, Apostolou E, Akutsu H, et al.: Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465(7295), 175-181 (2010).
261. Liu L, Luo GZ, Yang W, et al.: Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J. Biol. Chem. 285(25), 19483-19490 (2010).
262. Bonasio R, Tu S, Reinberg D: Molecular signals of epigenetic states. Science 330(6004), 612-616 (2010).
263. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A: An operational definition of epigenetics. Genes Dev. 23(7), 781-783 (2009).
264. Lengner CJ, Gimelbrant AA, Cheung WA, et al.: Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141(5), 872-883 (2010).
265. Nakamura T, Arai Y, Umehara H, et al.: PGC7/Stella protects against DNA demethylation in early embryogenesis. Nat. Cell Biol. 9(1), 64-71 (2007). (Pubitemid 46024198)
266. Singh AM, Hamazaki T, Hankowski KE, Terada N: A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 25(10), 2534-2542 (2007). (Pubitemid 47582745)
267. Graf T, Stadtfeld M: Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 3(5), 480-483 (2008).
268. Hayashi K, Lopes SM, Tang F, Surani MA: Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3(4), 391-401 (2008).
269. Wray J, Kalkan T, Smith AG: The ground state of pluripotency. Biochem. Soc. Trans. 38, 1027-1032 (2010).